Optimi Health Cultivation and Analytical Facilities
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
December 07, 2023 07:30 ET | Optimi Health Corp.
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
Photo Collage (Optimi)
Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing
November 28, 2023 07:42 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health...
OptimiTM-03.jpg
Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer
November 07, 2023 07:30 ET | Optimi Health Corp.
Optimi Health Introduces New Chief Science Officer Dr. Preston A. Chase.
OptimiTM-03.jpg
Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing
November 02, 2023 07:30 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
OptimiTM-03.jpg
Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program
September 07, 2023 07:30 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly...
OptimiTM-03.jpg
Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing
September 05, 2023 07:30 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
headshots-jj-wilson-optimi-3
Optimi Health Announces CAD $3,000,000 Senior Debt Financing
August 10, 2023 07:30 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada...
OptimiTM-03.jpg
Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent
August 01, 2023 07:30 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
OptimiTM-03.jpg
Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
June 15, 2023 09:40 ET | Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
OptimiTM-03.jpg
Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market
May 17, 2023 08:15 ET | Optimi Health Corp.
VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...